230 related articles for article (PubMed ID: 11544480)
1. Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease.
MacDonald TJ; Brown KM; LaFleur B; Peterson K; Lawlor C; Chen Y; Packer RJ; Cogen P; Stephan DA
Nat Genet; 2001 Oct; 29(2):143-52. PubMed ID: 11544480
[TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of PDGFR-RAS/MAPK pathway activation in childhood medulloblastoma.
Gilbertson RJ; Langdon JA; Hollander A; Hernan R; Hogg TL; Gajjar A; Fuller C; Clifford SC
Eur J Cancer; 2006 Mar; 42(5):646-9. PubMed ID: 16434186
[TBL] [Abstract][Full Text] [Related]
3. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
[TBL] [Abstract][Full Text] [Related]
4. Different inhibitory effect of imatinib on phosphorylation of mitogen-activated protein kinase and Akt and on proliferation in cells expressing different types of mutant platelet-derived growth factor receptor-alpha.
Ohashi A; Kinoshita K; Isozaki K; Nishida T; Shinomura Y; Kitamura Y; Hirota S
Int J Cancer; 2004 Sep; 111(3):317-21. PubMed ID: 15221957
[TBL] [Abstract][Full Text] [Related]
5. Aryl hydrocarbon receptor activation and cytochrome P450 1A induction by the mitogen-activated protein kinase inhibitor U0126 in hepatocytes.
Andrieux L; Langouët S; Fautrel A; Ezan F; Krauser JA; Savouret JF; Guengerich FP; Baffet G; Guillouzo A
Mol Pharmacol; 2004 Apr; 65(4):934-43. PubMed ID: 15044623
[TBL] [Abstract][Full Text] [Related]
6. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
Miranda MB; McGuire TF; Johnson DE
Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
[TBL] [Abstract][Full Text] [Related]
7. Rho/ROCK and MAPK signaling pathways are involved in glioblastoma cell migration and proliferation.
Zohrabian VM; Forzani B; Chau Z; Murali R; Jhanwar-Uniyal M
Anticancer Res; 2009 Jan; 29(1):119-23. PubMed ID: 19331140
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine-1-phosphate induces COX-2 expression via PI3K/Akt and p42/p44 MAPK pathways in rat vascular smooth muscle cells.
Hsieh HL; Wu CB; Sun CC; Liao CH; Lau YT; Yang CM
J Cell Physiol; 2006 Jun; 207(3):757-66. PubMed ID: 16508949
[TBL] [Abstract][Full Text] [Related]
9. Essential role of the ERK/MAPK pathway in blood-placental barrier formation.
Nadeau V; Charron J
Development; 2014 Jul; 141(14):2825-37. PubMed ID: 24948605
[TBL] [Abstract][Full Text] [Related]
10. Differential sensitivity of chemoresistant neuroblastoma subtypes to MAPK-targeted treatment correlates with ERK, p53 expression, and signaling response to U0126.
Eppstein AC; Sandoval JA; Klein PJ; Woodruff HA; Grosfeld JL; Hickey RJ; Malkas LH; Schmidt CM
J Pediatr Surg; 2006 Jan; 41(1):252-9. PubMed ID: 16410143
[TBL] [Abstract][Full Text] [Related]
11. Platelet-derived-growth-factor stimulation of the p42/p44 mitogen-activated protein kinase pathway in airway smooth muscle: role of pertussis-toxin-sensitive G-proteins, c-Src tyrosine kinases and phosphoinositide 3-kinase.
Conway AM; Rakhit S; Pyne S; Pyne NJ
Biochem J; 1999 Jan; 337 ( Pt 2)(Pt 2):171-7. PubMed ID: 9882612
[TBL] [Abstract][Full Text] [Related]
12. Amplification and overexpression of KIT, PDGFRA, and VEGFR2 in medulloblastomas and primitive neuroectodermal tumors.
Blom T; Roselli A; Häyry V; Tynninen O; Wartiovaara K; Korja M; Nordfors K; Haapasalo H; Nupponen NN
J Neurooncol; 2010 Apr; 97(2):217-24. PubMed ID: 19779861
[TBL] [Abstract][Full Text] [Related]
13. The use of gene expression analysis to gain insights into signaling mechanisms of metastatic medulloblastoma.
Chopra A; Brown KM; Rood BR; Packer RJ; MacDonald TJ
Pediatr Neurosurg; 2003 Jul; 39(2):68-74. PubMed ID: 12845196
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S
Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377
[TBL] [Abstract][Full Text] [Related]
15. A MEK inhibitor (U0126) prolongs survival in nude mice bearing human gallbladder cancer cells with K-ras mutation: analysis in a novel orthotopic inoculation model.
Horiuchi H; Kawamata H; Fujimori T; Kuroda Y
Int J Oncol; 2003 Oct; 23(4):957-63. PubMed ID: 12963974
[TBL] [Abstract][Full Text] [Related]
16. MMP-9 short interfering RNA induced senescence resulting in inhibition of medulloblastoma growth via p16(INK4a) and mitogen-activated protein kinase pathway.
Rao JS; Bhoopathi P; Chetty C; Gujrati M; Lakka SS
Cancer Res; 2007 May; 67(10):4956-64. PubMed ID: 17510426
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of VCAM-1 expression by tumor necrosis factor-alpha in human tracheal smooth muscle cells: involvement of MAPKs, NF-kappaB, p300, and histone acetylation.
Lee CW; Lin WN; Lin CC; Luo SF; Wang JS; Pouyssegur J; Yang CM
J Cell Physiol; 2006 Apr; 207(1):174-86. PubMed ID: 16288471
[TBL] [Abstract][Full Text] [Related]
18. Effects of U0126 on growth and activation of mitogen-activated protein kinases in Aspergillus fumigatus.
Ma DM; Ji YJ; Yang F; Liu W; Wan Z; Li RY
Chin Med J (Engl); 2013 Jan; 126(2):220-5. PubMed ID: 23324267
[TBL] [Abstract][Full Text] [Related]
19. HB-EGF-induced VEGF production and eNOS activation depend on both PI3 kinase and MAP kinase in HaCaT cells.
Nakai K; Yoneda K; Moriue T; Igarashi J; Kosaka H; Kubota Y
J Dermatol Sci; 2009 Sep; 55(3):170-8. PubMed ID: 19559571
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
Marampon F; Ciccarelli C; Zani BM
Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]